Nanotechnology: the next silver bullet?
A number of commentators during the past few years have speculated that nanotechnology is the wave of the future in biotech and pharma.
Pure water technology
Traditionally, in pharmaceutical water systems the main method for controlling bacterial levels was heat or chemical sanitants...
Rapid progress in pharma RFID
Drug companies have come to realize that spending heavily on creating new blockbuster drugs is risky and less cost-effective ...
Coenzyme Q10-loaded NLCs: preparation, occlusive properties and penetration enhancement
Fostering France's pharmaceutical recovery
Driven by a rapidly ageing population and a known high consumption of pharmaceuticals, the French pharmaceutical market has always appeared buoyant.
Profiling biopharma medicines
... the biotech industry could make characterization of its products easier by paying more attention to downstream processing and purification issues, creating a cleaner product that is easier to identify.
FDA's new guidance for industry
Anyone familiar with the USA v Barr Laboratories case of 1993 will recognize the importance of not ignoring OOS results, and the inappropriateness of testing into compliance.
Pharmaceutical LIMS — finding your way to the best solution
Vendors who insist on using older and outdated technologies will eventually suffer increased pressure to follow the lead of those who adopt new technologies.
The extrusion and spheronization of chitosan
Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.
